China · Delayed Price · Currency is CNY Jafron Biomedical Statistics
Total Valuation
SHE:300529 has a market cap or net worth of CNY 12.10 billion. The enterprise value is 10.71 billion.
| Market Cap | 12.10B |
| Enterprise Value | 10.71B |
Important Dates
The next estimated earnings date is Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | Jun 1, 2026 |
Share Statistics
SHE:300529 has 774.36 million shares outstanding. The number of shares has decreased by -2.52% in one year.
| Current Share Class | 774.36M |
| Shares Outstanding | 774.36M |
| Shares Change (YoY) | -2.52% |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | 50.93% |
| Owned by Institutions (%) | 8.81% |
| Float | 374.61M |
Valuation Ratios
The trailing PE ratio is 21.15 and the forward PE ratio is 19.18.
| PE Ratio | 21.15 |
| Forward PE | 19.18 |
| PS Ratio | 5.98 |
| PB Ratio | 3.27 |
| P/TBV Ratio | 3.37 |
| P/FCF Ratio | 22.19 |
| P/OCF Ratio | 17.09 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.50, with an EV/FCF ratio of 19.64.
| EV / Earnings | 18.98 |
| EV / Sales | 5.29 |
| EV / EBITDA | 12.50 |
| EV / EBIT | 14.50 |
| EV / FCF | 19.64 |
Financial Position
The company has a current ratio of 8.71, with a Debt / Equity ratio of 0.34.
| Current Ratio | 8.71 |
| Quick Ratio | 7.75 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 1.45 |
| Debt / FCF | 2.28 |
| Interest Coverage | 14.32 |
Financial Efficiency
Return on equity (ROE) is 15.60% and return on invested capital (ROIC) is 26.66%.
| Return on Equity (ROE) | 15.60% |
| Return on Assets (ROA) | 8.24% |
| Return on Invested Capital (ROIC) | 26.66% |
| Return on Capital Employed (ROCE) | 14.29% |
| Weighted Average Cost of Capital (WACC) | 6.27% |
| Revenue Per Employee | 879,881 |
| Profits Per Employee | 245,350 |
| Employee Count | 2,301 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.54 |
Taxes
In the past 12 months, SHE:300529 has paid 130.87 million in taxes.
| Income Tax | 130.87M |
| Effective Tax Rate | 18.83% |
Stock Price Statistics
The stock price has decreased by -25.39% in the last 52 weeks. The beta is 0.42, so SHE:300529's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -25.39% |
| 50-Day Moving Average | 17.96 |
| 200-Day Moving Average | 19.92 |
| Relative Strength Index (RSI) | 26.91 |
| Average Volume (20 Days) | 6,109,910 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300529 had revenue of CNY 2.02 billion and earned 564.55 million in profits. Earnings per share was 0.74.
| Revenue | 2.02B |
| Gross Profit | 1.56B |
| Operating Income | 739.05M |
| Pretax Income | 695.01M |
| Net Income | 564.55M |
| EBITDA | 854.53M |
| EBIT | 739.05M |
| Earnings Per Share (EPS) | 0.74 |
Balance Sheet
The company has 2.63 billion in cash and 1.24 billion in debt, with a net cash position of 1.39 billion or 1.80 per share.
| Cash & Cash Equivalents | 2.63B |
| Total Debt | 1.24B |
| Net Cash | 1.39B |
| Net Cash Per Share | 1.80 |
| Equity (Book Value) | 3.70B |
| Book Value Per Share | 4.70 |
| Working Capital | 2.69B |
Cash Flow
In the last 12 months, operating cash flow was 708.05 million and capital expenditures -162.70 million, giving a free cash flow of 545.35 million.
| Operating Cash Flow | 708.05M |
| Capital Expenditures | -162.70M |
| Depreciation & Amortization | 115.48M |
| Net Borrowing | -156.39M |
| Free Cash Flow | 545.35M |
| FCF Per Share | 0.70 |
Margins
Gross margin is 77.16%, with operating and profit margins of 36.50% and 27.88%.
| Gross Margin | 77.16% |
| Operating Margin | 36.50% |
| Pretax Margin | 34.33% |
| Profit Margin | 27.88% |
| EBITDA Margin | 42.21% |
| EBIT Margin | 36.50% |
| FCF Margin | 26.94% |
Dividends & Yields
This stock pays an annual dividend of 0.52, which amounts to a dividend yield of 3.28%.
| Dividend Per Share | 0.52 |
| Dividend Yield | 3.28% |
| Dividend Growth (YoY) | -35.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 113.94% |
| Buyback Yield | 2.52% |
| Shareholder Yield | 5.84% |
| Earnings Yield | 4.66% |
| FCF Yield | 4.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SHE:300529 is 24.12, which is 54.32% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 24.12 |
| Price Target Difference | 54.32% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 7.87% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on May 20, 2020. It was a forward split with a ratio of 1.9.
| Last Split Date | May 20, 2020 |
| Split Type | Forward |
| Split Ratio | 1.9 |
Scores
SHE:300529 has an Altman Z-Score of 7.64 and a Piotroski F-Score of 5.
| Altman Z-Score | 7.64 |
| Piotroski F-Score | 5 |